Your browser doesn't support javascript.
loading
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.
Suryamohan, Kushal; Diwanji, Devan; Stawiski, Eric W; Gupta, Ravi; Miersch, Shane; Liu, Jiang; Chen, Chao; Jiang, Ying-Ping; Fellouse, Frederic A; Sathirapongsasuti, J Fah; Albers, Patrick K; Deepak, Tanneeru; Saberianfar, Reza; Ratan, Aakrosh; Washburn, Gavin; Mis, Monika; Santhosh, Devi; Somasekar, Sneha; Hiranjith, G H; Vargas, Derek; Mohan, Sangeetha; Phalke, Sameer; Kuriakose, Boney; Antony, Aju; Ustav, Mart; Schuster, Stephan C; Sidhu, Sachdev; Junutula, Jagath R; Jura, Natalia; Seshagiri, Somasekar.
Afiliación
  • Suryamohan K; Research and Development Department, MedGenome Inc, Foster City, CA, USA.
  • Diwanji D; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.
  • Stawiski EW; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.
  • Gupta R; Research and Development Department, MedGenome Inc, Foster City, CA, USA.
  • Miersch S; MedGenome Labs Ltd., Bangalore, Karnataka, India.
  • Liu J; Department of Molecular Genetics, and the Terrence Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
  • Chen C; ModMab Therapeutics, Foster City, CA, USA.
  • Jiang YP; Department of Molecular Genetics, and the Terrence Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
  • Fellouse FA; ModMab Therapeutics, Foster City, CA, USA.
  • Sathirapongsasuti JF; ModMab Therapeutics, Accelerator for Donnelly Collaboration, University of Toronto, Toronto, ON, Canada.
  • Albers PK; Research and Development Department, MedGenome Inc, Foster City, CA, USA.
  • Deepak T; Wellcome Sanger Institute, Cambridge, UK.
  • Saberianfar R; MedGenome Labs Ltd., Bangalore, Karnataka, India.
  • Ratan A; ModMab Therapeutics, Accelerator for Donnelly Collaboration, University of Toronto, Toronto, ON, Canada.
  • Washburn G; Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
  • Mis M; Research and Development Department, MedGenome Inc, Foster City, CA, USA.
  • Santhosh D; Research and Development Department, MedGenome Inc, Foster City, CA, USA.
  • Somasekar S; ModMab Therapeutics, Foster City, CA, USA.
  • Hiranjith GH; Midwestern University, Glendale, AZ, USA.
  • Vargas D; Research and Development Department, MedGenome Inc, Foster City, CA, USA.
  • Mohan S; Research and Development Department, MedGenome Inc, Foster City, CA, USA.
  • Phalke S; Department of Molecular Biology, SciGenom Labs Pvt Ltd, Kochi, Kerala, India.
  • Kuriakose B; Department of Molecular Biology, SciGenom Labs Pvt Ltd, Kochi, Kerala, India.
  • Antony A; AgriGenome Labs Private Ltd, Kochi, Kerala, India.
  • Ustav M; Department of Molecular Biology, SciGenom Labs Pvt Ltd, Kochi, Kerala, India.
  • Schuster SC; Department of Molecular Genetics, and the Terrence Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
  • Sidhu S; Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Singapore.
  • Junutula JR; Department of Molecular Genetics, and the Terrence Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
  • Jura N; ModMab Therapeutics, Foster City, CA, USA.
  • Seshagiri S; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA. natalia.jura@ucsf.edu.
Commun Biol ; 4(1): 475, 2021 04 12.
Article en En | MEDLINE | ID: mdl-33846513

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polimorfismo Genético / Receptores Virales / Predisposición Genética a la Enfermedad / Mutación Missense / Enzima Convertidora de Angiotensina 2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Commun Biol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polimorfismo Genético / Receptores Virales / Predisposición Genética a la Enfermedad / Mutación Missense / Enzima Convertidora de Angiotensina 2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Commun Biol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos